Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Victoria Glover et al.|The Lancet Respiratory Medicine|2021Cited by 434
Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide ConsensusSanjay Ramakrishnan, Mona Bafadhel, Marco Contoli et al.|International Journal of COPD|2021Cited by 28
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Victoria Glover et al.|medRxiv|2021Cited by 25
Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a CICERO Clinical Research Collaboration–European Lung Foundation online patient surveyIwein Gyselinck, Roche, Richard Albert et al.|ERJ Open Research|2023Cited by 6
Inhaled Budesonide in the Treatment of Early COVID-19 Illness: A Randomised Controlled TrialSanjay Ramakrishnan, Mona Bafadhel, Jennifer Cane et al.|SSRN Electronic Journal|2021Cited by 5